Found 4 matching trials
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML PHASE1 This is a Phase 1, open-label, multicenter, dose-escalation \& expansion st...
Show More Location
The First Affiliated Hospital of Nanchang University
Learn More & Join Trial
Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML PHASE1 A Phase 1, Multicenter, Open-label, Dose-escalation Study to Evaluate Safet...
Show More Location
University of Michigan
Learn More & Join Trial
A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma PHASE1 This study is a multi-center, open-label, single-arm phase I clinical study...
Show More Location
the First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial
A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL PHASE2 The goal of this clinical trial is to evaluate the efficacy and safety of L...
Show More Location
The First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial